Показано 0 из 0
Дата |
---|
22:13 |
09.05.2024 |
08.05.2024 |
07.05.2024 |
06.05.2024 |
03.05.2024 |
02.05.2024 |
01.05.2024 |
30.04.2024 |
29.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
1.23
|
1.25
|
1.24
|
1.2201
|
1.26
|
1.23
|
|
|
19 510.58
|
115.00
|
1.22
|
1.29
|
1.23
|
1.2143
|
1.24
|
1.23
|
|
|
22 359.01
|
161.00
|
1.17
|
1.25
|
1.25
|
1.18
|
1.27
|
1.23
|
|
|
32 091.81
|
151.00
|
1.21
|
1.32
|
1.23
|
1.22
|
1.25
|
1.23
|
|
|
44 491.30
|
178.00
|
1.18
|
1.25
|
1.21
|
1.20
|
1.24
|
1.21
|
|
|
112 438.05
|
249.00
|
1.17
|
1.24
|
1.1901
|
1.19
|
1.23
|
1.20
|
|
|
37 244.12
|
262.00
|
1.20
|
1.24
|
1.19
|
1.19
|
1.2125
|
1.19
|
|
|
38 797.71
|
201.00
|
1.17
|
1.23
|
1.23
|
1.19
|
1.23
|
1.21
|
|
|
43 028.85
|
194.00
|
1.20
|
1.24
|
1.20
|
1.20
|
1.24
|
1.20
|
|
|
46 947.23
|
192.00
|
1.19
|
1.29
|
1.24
|
1.18
|
1.25
|
1.23
|
|
|
63 653.84
|
215.00
|
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada.